SB-239063AN
p38 MAPK inhibitor; different than SB-239063
Also Known As:
1-(1,3-dihydroxyprop-2-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl)imidazole
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Behm, David J:
2 articles
(04/2005 - 12/2003)
|
2. | Eybye, Marianne E:
2 articles
(04/2005 - 12/2003)
|
3. | Olzinski, Alan R:
2 articles
(04/2005 - 12/2003)
|
4. | Willette, Robert N:
2 articles
(04/2005 - 12/2003)
|
5. | Bentley, Ross:
1 article
(04/2005)
|
6. | Coatney, Robert W:
1 article
(04/2005)
|
7. | Frazier, Kendall S:
1 article
(04/2005)
|
8. | Maniscalco, Kristeen:
1 article
(04/2005)
|
9. | McCafferty, Tara A:
1 article
(04/2005)
|
10. | Milliner, Chavon M:
1 article
(04/2005)
|
Related Diseases
Related Drugs and Biologics